BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 36975415)

  • 1.
    Li D; Huang S; Luo C; Xu Y; Fu S; Liu K; Wu J
    Curr Oncol; 2023 Feb; 30(3):2653-2672. PubMed ID: 36975415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Advances in the Study of Chemokine-like Factor Superfamily Members in Tumors].
    Xie G; Cheng J; Zhang J
    Zhongguo Fei Ai Za Zhi; 2023 Jan; 26(1):46-51. PubMed ID: 36792080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance and immune characteristics of CMTM4 in hepatocellular carcinoma.
    Tan S; Guo X; Bei C; Zhang H; Li D; Zhu X; Tan H
    BMC Cancer; 2022 Aug; 22(1):905. PubMed ID: 35986302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Research Advances in CKLF-like MARVEL Transmembrane Domain-containing Family in Non-small Cell Lung Cancer.
    Wu K; Li X; Gu H; Yang Q; Liu Y; Wang L
    Int J Biol Sci; 2019; 15(12):2576-2583. PubMed ID: 31754330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CKLF-Like MARVEL Transmembrane Domain-Containing Member 3 (CMTM3) Inhibits the Proliferation and Tumorigenisis in Hepatocellular Carcinoma Cells.
    Li W; Zhang S
    Oncol Res; 2017 Jan; 25(2):285-293. PubMed ID: 27629543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Research insights into the chemokine-like factor (CKLF)-like MARVEL transmembrane domain-containing family (CMTM): their roles in various tumors.
    Duan SL; Jiang Y; Li GQ; Fu W; Song Z; Li LN; Li J
    PeerJ; 2024; 12():e16757. PubMed ID: 38223763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioinformatics analysis of CMTM family in pan-cancer and preliminary exploration of CMTM6 in bladder cancer.
    Xu Y; Li Q; Lin H
    Cell Signal; 2024 Mar; 115():111012. PubMed ID: 38113979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of CMTM4 Sensitizes Cholangiocarcinoma and Hepatocellular Carcinoma to T Cell-Mediated Antitumor Immunity Through PD-L1.
    Chui NN; Cheu JW; Yuen VW; Chiu DK; Goh CC; Lee D; Zhang MS; Ng IO; Wong CC
    Hepatol Commun; 2022 Jan; 6(1):178-193. PubMed ID: 34558800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulated CMTM2 Poses Potential Clinical Significance in Hepatocellular Carcinoma.
    Guo X; Zhang S; Tan S; Bei C; Zhang H; Zhu X; Qiu X
    DNA Cell Biol; 2020 Apr; 39(4):683-689. PubMed ID: 31990600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemokine-like factor-like MARVEL transmembrane domain-containing family in autoimmune diseases.
    Duan HJ; Li XY; Liu C; Deng XL
    Chin Med J (Engl); 2020 Apr; 133(8):951-958. PubMed ID: 32195671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CMTM5/7 are biomarkers and prognostic factors in human breast carcinoma.
    Wu J
    Cancer Biomark; 2020; 29(1):89-99. PubMed ID: 32568178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of CMTM4 expression in hepatocellular carcinoma.
    Bei C; Zhang Y; Wei R; Zhu X; Wang Z; Zeng W; Chen Q; Tan S
    Onco Targets Ther; 2017; 10():5439-5443. PubMed ID: 29180877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive analysis of the prognostic value of the chemokine-like factor-like MARVEL transmembrane domain-containing family in gastric cancer.
    Liang Z; Xie J; Huang L; Huang Y; Zhang Y; Ma R; Zheng Z; Wang Q; Li X
    J Gastrointest Oncol; 2021 Apr; 12(2):388-406. PubMed ID: 34012634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of CMTM7 inhibits cell growth and migration in liver cancer.
    Huang ZM; Li PL; Yang P; Hou XD; Yang YL; Xu X; Xu F
    Kaohsiung J Med Sci; 2019 Jun; 35(6):332-340. PubMed ID: 30903681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible effects of chemokine-like factor-like MARVEL transmembrane domain-containing family on antiphospholipid syndrome.
    Ge YY; Duan HJ; Deng XL
    Chin Med J (Engl); 2021 Apr; 134(14):1661-1668. PubMed ID: 33813507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive analysis of N6-methyladenosine -related long non-coding RNAs and immune cell infiltration in hepatocellular carcinoma.
    Yu ZL; Zhu ZM
    Bioengineered; 2021 Dec; 12(1):1708-1724. PubMed ID: 33955330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association Between Polymorphisms in CMTM Family Genes and Hepatocellular Carcinoma in Guangxi of China.
    Bei C; Tan C; Zhu X; Wang Z; Tan S
    DNA Cell Biol; 2018 Aug; 37(8):691-696. PubMed ID: 29990439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic investigation of CMTM family genes suggests relevance to glioblastoma pathogenesis and CMTM1 and CMTM3 as priority targets.
    Delic S; Thuy A; Schulze M; Proescholdt MA; Dietrich P; Bosserhoff AK; Riemenschneider MJ
    Genes Chromosomes Cancer; 2015 Jul; 54(7):433-43. PubMed ID: 25931111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemokine-Like Factor-Like MARVEL Transmembrane Domain-Containing Family in Hepatocellular Carcinoma: Latest Advances.
    Li M; Luo F; Tian X; Yin S; Zhou L; Zheng S
    Front Oncol; 2020; 10():595973. PubMed ID: 33282744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of prognostic biomarkers in the CMTM family genes of human ovarian cancer through bioinformatics analysis and experimental verification.
    Zhang M; Wang J; Yue H; Zhang L
    Front Genet; 2022; 13():918319. PubMed ID: 36110202
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.